Login / Signup

Comments on efficacy and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and diabetes mellitus.

Selda MuratBektas MuratBulent Gorenek
Published in: Acta cardiologica (2021)
Keyphrases
  • oral anticoagulants
  • atrial fibrillation
  • glycemic control
  • direct oral anticoagulants
  • type diabetes
  • metabolic syndrome
  • venous thromboembolism
  • skeletal muscle
  • insulin resistance